1.
Jeong S, Tsai M-J, Shen C, Hsu Y-H. Falls, fracture and frailty risk in multiple sclerosis: a Mendelian Randomization study to identify shared genetics. Journal of bone and mineral metabolism. 2024. doi:10.1007/s00774-024-01504-8.
1.
Tanasescu R, Frakich N, Chou I-J, et al. Natalizumab Treatment of Relapsing Remitting Multiple Sclerosis Has No Long-Term Effects on the Proportion of Circulating Regulatory T Cells. Neurology and therapy. 2023. doi:10.1007/s40120-023-00539-9.
1.
Rojo D, Dal Cengio L, Badner A, et al. BMAL1 loss in oligodendroglia contributes to abnormal myelination and sleep. Neuron. 2023. doi:10.1016/j.neuron.2023.08.002.
1.
Dhand A, White CC, Johnson C, Xia Z, De Jager PL. A scalable online tool for quantitative social network assessment reveals potentially modifiable social environmental risks. Nat Commun. 2018;9(1):3930. doi:10.1038/s41467-018-06408-6.
1.
De Jager PL. Is the goal of an epigenomic study to determine causality?. Mult Scler. 2018;24(7):908-909. doi:10.1177/1352458517750771.
1.
Quintana FJ, Prinz M. A gut feeling about multiple sclerosis. Proc Natl Acad Sci U S A. 2017;114(40):10528-10529. doi:10.1073/pnas.1714260114.
1.
Manousaki D, Dudding T, Haworth S, et al. Low-Frequency Synonymous Coding Variation in CYP2R1 Has Large Effects on Vitamin D Levels and Risk of Multiple Sclerosis. Am J Hum Genet. 2017;101(2):227-238. doi:10.1016/j.ajhg.2017.06.014.
1.
Felsky D, Patrick E, Schneider JA, et al. Polygenic analysis of inflammatory disease variants and effects on microglia in the aging brain. Mol Neurodegener. 2018;13(1):38. doi:10.1186/s13024-018-0272-6.
1.
Kowalec K, Wright GEB, Drögemöller BI, et al. Common variation near IRF6 is associated with IFN-β-induced liver injury in multiple sclerosis. Nat Genet. 2018;50(8):1081-1085. doi:10.1038/s41588-018-0168-y.
1.
Quintana FJ. Astrocytes play a crucial role in the formation and evolution of MS lesions - Commentary. Mult Scler. 2019;25(1):19-20. doi:10.1177/1352458518796693.